CytomX Therapeutics Stock Forecast - Accumulation Distribution

CTMX Stock  USD 0.87  0  0.34%   
CytomX Stock Forecast is based on your current time horizon.
  
At this time, CytomX Therapeutics' Payables Turnover is fairly stable compared to the past year. Asset Turnover is likely to rise to 0.53 in 2024, whereas Receivables Turnover is likely to drop 28.02 in 2024. . Common Stock Shares Outstanding is likely to drop to about 48.9 M in 2024. Net Loss is likely to drop to about (109.5 M) in 2024.
CytomX Therapeutics has current Accumulation Distribution of 0. The accumulation distribution (A/D) indicator shows the degree to which CytomX Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of CytomX Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by CytomX Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check CytomX Therapeutics VolatilityBacktest CytomX TherapeuticsInformation Ratio  

CytomX Therapeutics Trading Date Momentum

On November 22 2024 CytomX Therapeutics was traded for  0.87  at the closing time. The top price for the day was 0.87  and the lowest listed price was  0.87 . There was no trading activity during the period 0.0. Lack of trading volume on November 22, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.35% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare CytomX Therapeutics to competition

Other Forecasting Options for CytomX Therapeutics

For every potential investor in CytomX, whether a beginner or expert, CytomX Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. CytomX Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in CytomX. Basic forecasting techniques help filter out the noise by identifying CytomX Therapeutics' price trends.

CytomX Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CytomX Therapeutics stock to make a market-neutral strategy. Peer analysis of CytomX Therapeutics could also be used in its relative valuation, which is a method of valuing CytomX Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

CytomX Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of CytomX Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of CytomX Therapeutics' current price.

CytomX Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how CytomX Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CytomX Therapeutics shares will generate the highest return on investment. By undertsting and applying CytomX Therapeutics stock market strength indicators, traders can identify CytomX Therapeutics entry and exit signals to maximize returns.

CytomX Therapeutics Risk Indicators

The analysis of CytomX Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in CytomX Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cytomx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CytomX Stock Analysis

When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.